Feb. 7, 2025
U.S. Reps. Greg Murphy, MD (R-NC), Jimmy Panetta (D-CA) and eight other representatives from both the Republican and Democrat parties introduced the Medicare Patient Access and Practice Stabilization Act (H.R. 879) Jan. 31. The legislation, which would take effect April 1, if passed by Congress and signed into law by President Trump, would add 6.62% to the Medicare Physician Fee Schedule (MPFS) conversion factor (CF) for the remainder of 2025.

H.R. 879 mirrors bipartisan legislation introduced in 2024, that was not included in the continuing resolution passed by Congress in December to fund the government through March. The current CF is roughly 2.83% below 2024 CF. 

H.R. 897 would: restore the 2.93% Congressional increase from 2024; account for inflationary pressures; and be prorated to reflect a lower CF during the first quarter of 2025. 

The American College of Radiology® (ACR®) is advocating for H.R. 879 to be included in the March continuing resolution to fund the government.  

For more information or if you have any questions, contact Rebecca Spangler, ACR Senior Government Relations Director. 

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more